2 January 2025
Tern Plc
("Tern" or the "Company")
Investment in Sure Ventures plc
Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, announces that the Company has invested
For its cash consideration of
Sure Ventures is a venture capital fund which invests in early-stage software companies in the rapidly growing technology areas of Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR) and IoT. It is listed on the Specialist Fund Segment of the London Stock Exchange with a reported net asset value per share, as at 30 September 2024, of
Sure Ventures' principal investments are a 25.9% interest in Sure Valley Ventures Fund ("SVV1") and an approximate 6% interest in Sure Valley Enterprise Capital Fund ("SVV2"). Tern already has a direct 5.9% interest in SVV2.
The Tern directors believe that this investment in Sure Ventures will provide Tern with the following benefits:
· Exposure to a complimentary portfolio of specialist technology businesses at an attractive discount to Sure Ventures' current net asset value, in particular its interest in SVV1's portfolio.
· Provide Tern with increased diversity of exposure to specialist technology businesses at different stages of development to Tern's current key portfolio companies, Device Authority, FundamentalVR and Talking Medicines.
· Further enhance Tern's existing relationship with SVV2 and the ability to leverage potential synergies between Tern's portfolio companies and those held by SVV1 and SVV2.
· Potentially provide income to Tern from any distributions undertaken by Sure Ventures following SVV1 and SVV2 portfolio exits, including liquidity events already announced by Sure Ventures.
Online Investor Presentation and Q&A Session
As previously announced, the Company will be hosting an online presentation and Q&A session at 5.30 p.m. GMT on Thursday 9 January 2025.
Presenting will be members of Tern's management team and management from Tern's portfolio companies Device Authority, FundamentalVR and Talking Medicines, together with a representative of Vortex IQ, a SVV2 portfolio company. This session is open to all existing and prospective shareholders. Those who wish to attend should register via the following link where they will be provided with access details:
https://us02web.zoom.us/webinar/register/WN_95cYxDkWQPqzY9IK-nLoUQ
Participants will have the opportunity to submit questions during the session, but questions are welcomed in advance and may be submitted prior to 3 p.m. GMT on 8 January 2025 to: tern@investor-focus.co.uk.
Enquiries
Tern Plc Ian Ritchie (Chairman) |
via IFC Advisory |
Allenby Capital Limited (Nominated Adviser and Broker) Alex Brearley / Dan Dearden-Williams (Corporate Finance) Kelly Gardiner / Guy McDougall (Sales and Corporate Broking) |
Tel: 0203 328 5656 |
IFC Advisory (Financial PR and IR) Tim Metcalfe Graham Herring Florence Chandler |
Tel: 0203 934 6630 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.